Confined or spread disease-Confined only to the breast - Page 7 of 9 Posts on Medivizor
Navigation Menu

Confined or spread disease-Confined only to the breast Posts on Medivizor

Better looking breasts with IMRT

Better looking breasts with IMRT

Posted by on Oct 24, 2013 in Breast cancer | 0 comments

In a nutshell This study investigated the cosmetic benefits of intensity modulated radiation therapy (IMRT) compared to standard radiotherapy for the treatment of breast cancer. Some background Radiation therapy is commonly used to treat breast cancer. It is often used following surgery to destroy any remaining cancer cells and prevent recurrence...

Read More

A new treatment option for breast cancer

A new treatment option for breast cancer

Posted by on Sep 23, 2013 in Breast cancer | 1 comment

In a nutshell This phase II clinical trial examined the safety and efficacy of adding a drug called rh-endostatin (Endostar) to chemotherapy in breast cancer patients. Some background Cancer cells need blood supply in order to grow. As cancer grows, it forms its own blood vessels, a process called angiogenesis. Therefore, anti-angiogenesis...

Read More

Some traits of lobular in-situ neoplasia can predict the risk of developing invasive breast cancer

Some traits of lobular in-situ neoplasia can predict the risk of developing invasive breast cancer

Posted by on Aug 26, 2013 in Breast cancer | 0 comments

In a nutshell In this study researchers investigated which traits of lobular in-situ neoplasia (LN) are likely to predict upgrade to invasive breast cancer. Some background LN is the presence of abnormal cells in the lobules (milk-producing glands) of the breast. LN includes 2 conditions which are considered to increase the risk of developing...

Read More

The benefits of beta-blocker treatment in triple negative breast cancer patients

Posted by on Aug 21, 2013 in Breast cancer | 0 comments

In a nutshell This study investigated the potential benefit of beta blocker treatment in triple negative breast cancer patients. In this study, patients already receiving long term treatment with beta blockers before the diagnosis of cancer were investigated to examine the effect on cancer outcome. Some background Beta blockers are a class of...

Read More

Do lymph node micrometastases and isolated tumor cells influence survival in breast cancer patients?

Do lymph node micrometastases and isolated tumor cells influence survival in breast cancer patients?

Posted by on Aug 20, 2013 in Breast cancer | 0 comments

In a nutshell In this study, researchers evaluated whether isolated tumor cells (ITC) or micrometastases can predict survival in breast cancer patients and whether there is need for additional treatments in these patients. Some background After surgery to treat breast cancer, many patients undergo a sentinel node biopsy (SNB). SNB is the...

Read More

Evaluating complication rate for removal of one or both breasts in patients with breast cancer

Evaluating complication rate for removal of one or both breasts in patients with breast cancer

Posted by on Jul 30, 2013 in Breast cancer | 0 comments

In a nutshell In this study, researchers examined whether breast cancer patients who chose to have preventive removal of both breasts (bilateral mastectomy or BM) experience more post-surgery complications than patients who have removed only the cancer-affected breast (unilateral mastectomy or UM). Some background Most women with early breast...

Read More

Evaluating the effect on survival of long-term hormone therapy in breast cancer patients

Evaluating the effect on survival of long-term hormone therapy in breast cancer patients

Posted by on Jul 30, 2013 in Breast cancer | 0 comments

In a nutshell This study examined the impact on survival of more than 5 years of adjuvant hormonal therapy in breast cancer patients. Some background Some types of breast cancer grow in response to female sex hormones (estrogen and progesterone) via their receptor (a protein found on breast cells). These are called hormone receptor-positive (HR+)...

Read More

Does Oncotype DX testing reduce the use of chemotherapy in patients with estrogen receptor positive breast cancer?

Does Oncotype DX testing reduce the use of chemotherapy in patients with estrogen receptor positive breast cancer?

Posted by on Jul 9, 2013 in Breast cancer | 0 comments

In a nutshell In this study, researchers evaluated whether a genetic test called Oncotype DX, reduced the use of chemotherapy treatment for patients with node-positive and estrogen-receptor positive breast cancer. Some background Some breast cancers grow in response to estrogen, the main female sex hormone, via their receptor (a protein found on...

Read More

Comparing survival rates in women diagnosed with cancer in one or both breasts

Posted by on Jul 5, 2013 in Breast cancer | 0 comments

In a nutshell This study compared survival rates of patients who developed cancer in both breasts (called contralateral breast cancer or CBC) and patients who had cancer in one breast (unilateral breast cancer or UBC). Some background Breast cancer is the most common cancer among women. Breast cancer survivors are 3.5 times more likely to develop...

Read More